Paltusotine (CRN00808) is an orally active, nonpeptide selective somatostatin type 2 (SST2) receptor agonist. Paltusotine has the potential for maintaining GH and IGF-1 levels after depot somatostatin receptor ligand therapy.
Molecular Weight:
456.49
Purity:
99.0%
CAS Number:
[2172870-89-0]
Formula:
C27H22F2N4O
Target:
Somatostatin Receptor
* VAT and and shipping costs not included. Errors and price changes excepted